Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Gastroenterology,Hepatology
Reference5 articles.
1. Increased risk of COVID-among users of proton pump inhibitors;Almario;Am J Gastroenterol,2020
2. High prevalence of concurrent gastrointestinal manifestations in patients with SARS-CoV-2: Early experience from California;Cholankeril;Gastroenterology,2020
3. Retracted: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis;Mehra;The Lancet,2020
4. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin;Moayyedi;Gastroenterology,2019
5. SARS-CoV-2 testing, prevalence, and predictors of COVID-19 in patients with inflammatory bowel disease in Northern California;Gubatan;Gastroenterology,2020
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Proton pump inhibitors and risk of severe COVID-19 in older people;Age and Ageing;2024-04-01
2. The proton pump inhibitors use and COVID-19 from prior to vaccination perspective - a review;Digestive Diseases;2022-10-18
3. Proton Pump Inhibitors in the COVID-19 Pandemic;The Russian Archives of Internal Medicine;2022-07-29
4. Proton pump inhibitor therapy usage and associated hospitalization rates and critical care outcomes of COVID-19 patients;Scientific Reports;2022-05-09
5. Does Proton Pump Inhibitor Use Lead to a Higher Risk of Coronavirus Disease 2019 Infection and Progression to Severe Disease? a Meta-analysis;Japanese Journal of Infectious Diseases;2022-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3